Disease block
A30-A49 – Sonstige bakterielle Krankheiten
- Chapter I: Bestimmte infektiöse und parasitäre Krankheiten
12Decisions
16Patient groups
Added benefit by patient group
- Non-quantifiable1
- Deemed proven14
- Not proven1
Diseases in this disease block
- A31 Infektion durch sonstige Mykobakterien 1 decision
- A41 Sonstige Sepsis 7 decisions
- A46 Erysipel [Wundrose] 2 decisions
- A48 Sonstige bakterielle Krankheiten, anderenorts nicht klassifiziert 1 decision
- A49 Bakterielle Infektion nicht näher bezeichneter Lokalisation 10 decisions
Decisions, newest first
Each decision lists only the patient groups coded with a disease in this disease block.
- 2026-08-06RecarbrioImipenem/Cilastatin/RelebactamDeemed proven: 2 of 2 patient groups
- 2025-11-20XydalbaDalbavancinDeemed proven
- 2025-05-15ZaviceftaCeftazidim/AvibactamDeemed proven
- 2025-04-17VaboremMeropenem/VaborbactamDeemed proven: 2 of 2 patient groups
- 2025-02-20EmblaveoAztreonam/AvibactamDeemed proven
- 2024-12-05ExblifepCefepim/EnmetazobactamDeemed proven
- 2024-02-01XydalbaDalbavancinDeemed proven
- 2022-11-03ZaviceftaCeftazidim/AvibactamDeemed proven: 2 of 2 patient groups
- 2022-11-03RecarbrioImipenem/Cilastatin/RelebactamDeemed proven: 2 of 2 patient groups
- 2022-05-05FetcrojaCefiderocolDeemed proven
- 2022-01-06GiaprezaAngiotensin-II-AcetatNot proven
- 2021-05-20Arikayce liposomalAmikacinNon-quantifiable
Data status: 2026-10-29